Customer Profile
Varda
Varda Space Industries
Varda focuses on in-space manufacturing for pharmaceuticals and advanced alloys . The company uses microgravity through its W-Orbital spacecraft to produce these materials .
Investors in Rocket Lab should monitor Varda as a potential user of orbital services. The company has achieved technical milestones including the successful orbital reentry and recovery of its W-1 spacecraft in 2024 .
Investment Thesis
Varda focuses on in-space manufacturing for pharmaceuticals and advanced alloys . The company uses microgravity through its W-Orbital spacecraft to produce these materials .
Investors in Rocket Lab should monitor Varda as a potential user of orbital services. The company has achieved technical milestones including the successful orbital reentry and recovery of its W-1 spacecraft in 2024 .
Key Differentiators
- • Microgravity Manufacturing: Uses W-Orbital spacecraft to manufacture pharmaceuticals and advanced alloys .
- • Proven Recovery: Completed successful orbital reentry and recovery of the W-1 spacecraft in 2024 .
Risk Factors
- • Funding Uncertainty: Total funding is approximately $145M .
Rocket Lab Relationship
Insufficient data is available to quantify the specific revenue relationship between Varda and Rocket Lab's business segments (launches, components, spacecraft, or services).
Business Model
The company generates revenue through in-space manufacturing of pharmaceuticals and advanced alloys using W-Orbital spacecraft .
Technology
The company utilizes W-Orbital spacecraft to leverage microgravity for manufacturing .
Space Activity
Varda completed the orbital reentry and recovery of its W-1 spacecraft in 2024 .
Leadership
insufficient data
Funding
Varda has raised approximately $145M . The company completed a Series B round in 2022 . Notable investors include Founders Fund, Lux Capital, Prime Movers Lab, and GV (Google Ventures) .
No Missions Found
Varda has not launched with Rocket Lab yet
No news articles found
News mentioning Varda will appear here.